The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
Allison Cohen(Joslin Diabetes Center), Florence M. Brown, Sarosh Rana(University of Illinois Chicago), Tamara C. Takoudes(Hadassah Medical Center), Ravi Thadhani(Emory Healthcare), Julia Wenger(Harvard University Press), Shuling Fan(Hadassah Medical Center), Tamarra James‐Todd(Brigham and Women's Hospital), Brooke Lamparello(Joslin Diabetes Center), Jennifer Wyckoff(Michigan United), Elizabeth Halprin(Joslin Diabetes Center), Kee-Hak Lim(Hadassah Medical Center), Shanti Serdy(Joslin Diabetes Center), Gary L. Horowitz(Tufts University), S. Ananth Karumanchi(Cedars-Sinai Medical Center)
Cited by 53
Related Papers
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
|Journal of Clinical Investigation|2003|4k
Circulating Angiogenic Factors and the Risk of Preeclampsia
|New England Journal of Medicine|2004|3.6k
2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|2.4k
Preeclampsia
|Circulation Research|2019|2k
Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
|New England Journal of Medicine|2003|924